This brand name is authorized in France, Malta, Singapore, Tunisia, Turkey
The drug TRIVASTAL contains one active pharmaceutical ingredient (API):
1
Piribedil
UNII DO22K1PRDJ - PIRIBEDIL
|
Piribedil is a dopaminergic agonist (stimulates dopamine receptors and the cerebral dopaminergic pathways). |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TRIVASTAL Sustained release coated tablet | Web Search | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N04BC08 | Piribedil | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FR | Base de données publique des médicaments | Identifier(s): 61598530, 62551633 |
Country: MT | Medicines Authority | Identifier(s): MA066/01101 |
Country: SG | Health Sciences Authority | Identifier(s): 09947P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6353091 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699552140122 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.